19,934 Shares in Quanterix Co. (NASDAQ:QTRX) Acquired by GSA Capital Partners LLP

GSA Capital Partners LLP acquired a new position in Quanterix Co. (NASDAQ:QTRX) in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 19,934 shares of the company’s stock, valued at approximately $258,000. GSA Capital Partners LLP owned 0.05% of Quanterix at the end of the most recent quarter.

Several other large investors have also recently bought and sold shares of QTRX. nVerses Capital LLC bought a new position in Quanterix in the 3rd quarter valued at $60,000. SG Americas Securities LLC bought a new position in Quanterix in the 3rd quarter valued at $139,000. Canada Pension Plan Investment Board purchased a new stake in shares of Quanterix during the 2nd quarter valued at $140,000. Hsbc Holdings PLC raised its position in shares of Quanterix by 34.7% during the 2nd quarter. Hsbc Holdings PLC now owns 12,738 shares of the company’s stock valued at $164,000 after buying an additional 3,279 shares in the last quarter. Finally, Allspring Global Investments Holdings LLC raised its position in shares of Quanterix by 11.0% during the 2nd quarter. Allspring Global Investments Holdings LLC now owns 14,261 shares of the company’s stock valued at $188,000 after buying an additional 1,417 shares in the last quarter. 86.48% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of equities analysts recently commented on the stock. TD Cowen lifted their target price on shares of Quanterix from $13.50 to $16.00 and gave the stock a “hold” rating in a research report on Wednesday, November 13th. Scotiabank decreased their target price on shares of Quanterix from $32.00 to $28.00 and set a “sector outperform” rating on the stock in a research report on Monday, August 12th.

Quanterix Trading Up 0.3 %

Shares of NASDAQ:QTRX opened at $11.75 on Friday. Quanterix Co. has a 12 month low of $10.50 and a 12 month high of $29.70. The company has a 50-day moving average price of $12.86 and a 200-day moving average price of $13.79. The company has a market cap of $450.97 million, a price-to-earnings ratio of -11.19 and a beta of 1.36.

Quanterix Company Profile

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications.